BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 14, 2010
View Archived Issues
New Inhibitor Keeps Hepatitis C from Getting Itself Together
Read More
Fate Strikes Technology Deal to Expand R&D IPSC Tools
Read More
Corrections & Clarifications
Read More
FDA Calls for Bone Fracture Warnings on Bisphosphonates
Read More
Clinic Roundup
Read More
Stock Movers
Read More
Other News To Note
Read More
Alkermes Aims Higher with New Indication for Vivitrol
With its FDA approval this week, Vivitrol becomes the first non-addictive, non-narcotic, once-monthly treatment for opioid dependence, serving a potential market of 1.3 million addicts in the U.S. (BioWorld Today)
Read More
Regeneron Raises $175.1M in Upsized Public Offering
Read More